FOCUS trial: results, potentialities and limits
Saba, LucaFirst
;Balestrieri, Antonella;Serra, Alessandra;Politi, Carola;Murgia, Alessandro;Mannelli, Lorenzo
2019-01-01
Abstract
In January 2019 Lancet has published the paper “Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial” (1). The main purpose of this prospective trial was to asses if fluoxetine [a selective serotonin reuptake inhibitor (SSRI) drug] could improve recovery after stroke.File | Size | Format | |
---|---|---|---|
atm-07-S3-S152(1).pdf Solo gestori archivio
Size 166.12 kB
Format Adobe PDF
|
166.12 kB | Adobe PDF | & nbsp; View / Open Request a copy |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.